Status:
UNKNOWN
GBR 12909 Study in Cocaine Experienced African American Volunteers - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.
Detailed Description
Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematologic...
Eligibility Criteria
Inclusion
- Must be within 20% of ideal body weight and must weigh at least 45 kg.
- Must understand the study procedures and provide written informed consent.
- Must meet DSM-4 criteria for abuse or dependence on cocaine.
- Must be non-treatment seeking at the time of the study.
Exclusion
- Please contact the study site for more information.
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
May 1 2005
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00089687
Start Date
April 1 2004
End Date
May 1 2005
Last Update
January 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uniformed Services University of Health Science
Bethesda, Maryland, United States, 20814 4799